Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Journal: Cancer cell
Published: February 01, 2022
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.
Journal: Science signaling
Published: July 19, 2018
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.
Journal: Journal of hematology & oncology
Published: July 13, 2017
Therapeutically Targetable ALK Mutations in Leukemia.
Journal: Cancer research
Published: June 03, 2015
JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model.
Journal: Experimental hematology
Published: May 22, 2015
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
Journal: Cancer research
Published: March 27, 2015
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 03, 2014
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
Journal: The Journal of biological chemistry
Published: January 10, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026